VEG111485: A Phase I, Randomized, Double-Blinded, Placebo- Controlled Study to Evaluate the Effect of Repeat Oral Doses of Pazopanib (GW786034) on Cardiac Conduction in Subjects With Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 24 Jan 2011
At a glance
- Drugs Moxifloxacin; Pazopanib
- Indications Bacterial infections; Solid tumours
- Focus Pharmacodynamics
- 06 Apr 2010 Actual patient number (96) added, actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 06 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.